RZRYFXHNIGIOTG-UHFFFAOYSA-N
C31H40F3N11O2S — CID 155688508
Data last refreshed: (MolForge compound catalog, from PubChem)
About RZRYFXHNIGIOTG-UHFFFAOYSA-N
RZRYFXHNIGIOTG-UHFFFAOYSA-N (PubChem CID 155688508) has the molecular formula C31H40F3N11O2S and a molecular weight of 687.80 g/mol. Its IUPAC name is N-[1-(1-methylimidazol-4-yl)sulfonylpiperidin-4-yl]-4-[1-[2-methyl-6-[(4-propan-2-ylpiperazin-1-yl)methyl]-3-pyridinyl]pyrazol-4-yl]-5-(trifluoromethyl)pyrimidin-2-amine.
Molecular Properties
| Compound Name | RZRYFXHNIGIOTG-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 155688508 |
| Molecular Formula | C31H40F3N11O2S |
| Molecular Weight | 687.80 g/mol |
| Exact Mass | 687.30 |
| IUPAC Name | N-[1-(1-methylimidazol-4-yl)sulfonylpiperidin-4-yl]-4-[1-[2-methyl-6-[(4-propan-2-ylpiperazin-1-yl)methyl]-3-pyridinyl]pyrazol-4-yl]-5-(trifluoromethyl)pyrimidin-2-amine |
| SMILES | Cc1nc(CN2CCN(C(C)C)CC2)ccc1-n1cc(-c2nc(NC3CCN(S(=O)(=O)c4cn(C)cn4)CC3)ncc2C(F)(F)F)cn1 |
| InChI | InChI=1S/C31H40F3N11O2S/c1-21(2)43-13-11-42(12-14-43)18-25-5-6-27(22(3)38-25)45-17-23(15-37-45)29-26(31(32,33)34)16-35-30(40-29)39-24-7-9-44(10-8-24)48(46,47)28-19-41(4)20-36-28/h5-6,15-17,19-21,24H,7-14,18H2,1-4H3,(H,35,39,40) |
| InChIKey | RZRYFXHNIGIOTG-UHFFFAOYSA-N |
| XLogP | 3.58 |
| TPSA | 130.20 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 687.80 |
| LogP ≤ 5 | 3.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155688508 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.